Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
September 24, 2004
Microvascular development: learning from pancreatic islets
Irena Konstantinova, Eckhard Lammert
Journal of Cell Communication and Signaling
|
February 7, 2015
A functional analysis of Wnt inducible signalling pathway protein -1 (WISP-1/CCN4)
Sarah Stephens, Joanne Palmer, Irena Konstantinova, et al.
Cell
|
April 24, 2007
EphA-Ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets
Irena Konstantinova, Ganka Nikolova, Mica Ohara-Imaizumi, et al.
Developmental Cell
|
March 7, 2006
The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation
Ganka Nikolova, Normund Jabs, Irena Konstantinova, et al.
Annals of the Rheumatic Diseases
|
August 13, 2017
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension
Jerome Avouac, Irena Konstantinova, Christophe Guignabert, et al.
Arthritis Research & Therapy
|
September 7, 2021
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis
Emma Derrett-Smith, Kristina E N Clark, Xu Shiwen, et al.
Nature
|
December 24, 2004
An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division
Ralf Kittler, Gabriele Putz, Laurence Pelletier, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 23, 2012
Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression
Loredana Ciuclan, Martin J Hussey, Victoria Burton, et al.
Hepatology Communications
|
February 7, 2018
The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis
Guillaume Wettstein, Jean-Michel Luccarini, Laurence Poekes, et al.
Journal of Medicinal Chemistry
|
August 10, 2016
Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension
Duncan E Shaw, Ferheen Baig, Ian Bruce, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
September 24, 2004
Microvascular development: learning from pancreatic islets
Irena Konstantinova, Eckhard Lammert
Journal of Cell Communication and Signaling
|
February 7, 2015
A functional analysis of Wnt inducible signalling pathway protein -1 (WISP-1/CCN4)
Sarah Stephens, Joanne Palmer, Irena Konstantinova, et al.
Cell
|
April 24, 2007
EphA-Ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets
Irena Konstantinova, Ganka Nikolova, Mica Ohara-Imaizumi, et al.
Developmental Cell
|
March 7, 2006
The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation
Ganka Nikolova, Normund Jabs, Irena Konstantinova, et al.
Annals of the Rheumatic Diseases
|
August 13, 2017
Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension
Jerome Avouac, Irena Konstantinova, Christophe Guignabert, et al.
Arthritis Research & Therapy
|
September 7, 2021
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis
Emma Derrett-Smith, Kristina E N Clark, Xu Shiwen, et al.
Nature
|
December 24, 2004
An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division
Ralf Kittler, Gabriele Putz, Laurence Pelletier, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 23, 2012
Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression
Loredana Ciuclan, Martin J Hussey, Victoria Burton, et al.
Hepatology Communications
|
February 7, 2018
The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis
Guillaume Wettstein, Jean-Michel Luccarini, Laurence Poekes, et al.
Journal of Medicinal Chemistry
|
August 10, 2016
Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension
Duncan E Shaw, Ferheen Baig, Ian Bruce, et al.
Page
of 1